Eileen Oldfield Associate Editor

The latest lung cancer screening recommendations suggest that heavy smokers be screened for the disease annually once they reach 55 years of age.

A study analyzing drug approvals and risk evaluation and mitigation strategies (REMS) approvals suggests that most therapies with REMS are indicated for large patient populations and are approved using standard, rather than accelerated, pathways.

UCB Pharma submitted a supplement to its new drug application for lacosamide (Vimpat) that would allow it to serve as monotherapy in patients with partial-onset seizures.

Pediatric patients with acute lymphoblastic leukemia showed better response to the flu vaccine if they received it at a certain point during chemotherapy.

Carfilzomib's ability to inhibit myeloma cell growth and ability to trigger a greater response in proteins associated with cell death than other therapies makes it a promising therapy for multiple myeloma patients.

A Novartis-sponsored study found better continuation rates and higher adherence in participants receiving oral disease-modifying therapy for multiple sclerosis.

A number of pharmacies around the country are using devices that identify authorized staff through biometric information such as fingerprints.

Spending on specialty medications is expected to increase 30% by 2017, a report from the IMS Institute for Healthcare Informatics predicts.

Despite lower costs for inpatient and outpatient appointments and surgery for patients receiving infliximab therapy, the costs to administer the therapy make it more expensive than adalimumab therapy.

A CVS Caremark report predicts further increases in specialty drug spending but suggests strategies for payers to manage costs.

Infliximab therapy has the potential to induce remission in pediatric Crohn's disease patients, but loss of response to the therapy remains a concern.

New research examines the portrayals of pharmacists in television and in the movies.

Combination therapy in patients with psoriatic arthritis has a lower discontinuation rate than that of patients on monotherapy, but comes with a higher price tag.

For biopharmaceutical firms developing treatments for rare diseases, economic incentives are rarely the only reason to begin developing orphan drugs.

A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-name biologics provided that a number of criteria are met.

Medication nonadherence leads to billion dollar losses for pharmaceutical companies, a report indicates.

Patients are increasingly willing to visit pharmacy-based clinics for their health care needs, according to the results of a recent survey.

Our selection of invaluable pharmacy apps allows you to track drug interactions, share health care videos with patients, and much, much more--all with your mobile device.

A computer simulation suggests that coordinating MRSA prevention efforts in hospitals throughout a region would decrease MRSA prevalence more effectively than implementing prevention measures in a single hospital.

Pharmacists placed second among the country's most trusted professionals in a Gallup poll, retaining a spot in the top 3 for the tenth consecutive year.

By downloading the Pharmacy Times AR application on an Android or Apple device, pharmacists can access the practical material they need in a vibrant new way.

Researchers are turning to Twitter, blogs, and online discussions to track adverse drug reactions.

Pharmacists can help identify patients with knee osteoarthritis and prompt them to begin treatment of the painful condition, a study suggests.

A diet low in meat and carbohydrates but with plenty of extra virgin olive oil appears to protect the bones of older men, according to the results of a study.

Pharmacists at new on-site pharmacies in 2 Florida hospitals offer patients medication counseling with the aim of reducing readmission rates.